Xiaoliang Wang

2.5k total citations
108 papers, 1.5k citations indexed

About

Xiaoliang Wang is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaoliang Wang has authored 108 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 25 papers in Oncology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaoliang Wang's work include Economic and Financial Impacts of Cancer (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Cardiac Ischemia and Reperfusion (7 papers). Xiaoliang Wang is often cited by papers focused on Economic and Financial Impacts of Cancer (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Cardiac Ischemia and Reperfusion (7 papers). Xiaoliang Wang collaborates with scholars based in China, United States and Germany. Xiaoliang Wang's co-authors include Huamei Tang, Chongzhi Zhou, Dongwang Yan, Junwei Fan, Zhihai Peng, Guoqiang Qiu, Dawei Li, Shuxia Li, Xianghua Xu and Yaping Pan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Xiaoliang Wang

103 papers receiving 1.5k citations

Peers

Countries citing papers authored by Xiaoliang Wang

Since Specialization

Citations

This map shows the geographic impact of Xiaoliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoliang Wang more than expected).

Fields of papers citing papers by Xiaoliang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoliang Wang. The network helps show where Xiaoliang Wang may publish in the future.

Co-authorship network of co-authors of Xiaoliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoliang Wang. A scholar is included among the top collaborators of Xiaoliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoliang Wang. Xiaoliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023 2024 ·JNCI Cancer Spectrum ·Jenny S. Guadamuz, Xiaoliang Wang, Ivy Altomare, (unknown), Somnath Sarkar, Ronac Mamtani, Gregory S. Calip	0
2	Are community oncology practices with or without clinical research programs different? A comparison of patient and practice characteristics 2024 ·JNCI Cancer Spectrum ·Ivy Altomare, Xiaoliang Wang, (unknown), Jenny S. Guadamuz, (unknown), (unknown), Neal J. Meropol, (unknown)	1
3	Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors 2024 ·JAMA Oncology ·Maureen Canavan, Xiaoliang Wang, Mustafa Ascha, Rebecca A. Miksad, Timothy N. Showalter, Gregory S. Calip, Cary P. Gross, Kerin B. Adelson	12
4	Association between posttreatment α‐fetoprotein reduction and outcomes in real‐world US patients with advanced hepatocellular carcinoma 2023 ·Cancer ·Ghassan K. Abou‐Alfa, Xiaoliang Wang, Christina M. Parrinello, Anala Gossai, Richard D. Kim, (unknown), Rebecca A. Miksad	5
5	Assessing the Contribution of Scanned Outside Documents to the Completeness of Real-World Data Abstraction 2023 ·JCO Clinical Cancer Informatics ·(unknown), Rachel Howard, Rossybelle P. Amorrortu, (unknown), Xiaoliang Wang, Gregory S. Calip, Dana E. Rollison	3
6	Identification of the potential biomarkers associated with circadian rhythms in heart failure 2023 ·PeerJ ·Qiang Sun, Jun Zhao, Li Liu, Xiaoliang Wang, Xinshun Gu	4
7	Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022 2023 ·JNCI Cancer Spectrum ·Jenny S. Guadamuz, Xiaoliang Wang, (unknown), Rebecca A. Miksad, Jeremy Snider, James Walters, Gregory S. Calip	27
8	Semiparametric Conditional Factor Models: Estimation and Inference 2023 ·SSRN Electronic Journal ·Qihui Chen, Nikolai Roussanov, Xiaoliang Wang	1
9	Immunotherapy Outcomes in Individuals With Non–Small Cell Lung Cancer and Poor Performance Status 2022 ·JNCI Cancer Spectrum ·Rajwanth Veluswamy, Liangyuan Hu, Cardinale B. Smith, Jiayi Ji, Xiaoliang Wang, Juan P. Wisnivesky, (unknown), Minal Kale	6
10	Real-world Use of Radiation for Newly Diagnosed Brain Metastases in Patients With ALK-positive Lung Cancer Receiving First-line ALK Inhibitor 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Sameera Kumar, Xiaoliang Wang, (unknown), Gregory S. Calip, Stephanie E. Weiss, Joshua E. Meyer, Trevor J. Royce	1
11	Mining Beneficial Genes for Salt Tolerance From a Core Collection of Rice Landraces at the Seedling Stage Through Genome-Wide Association Mapping 2022 ·Frontiers in Plant Science ·Xiaoliang Wang, Jinquan Li, (unknown), Shuang Gu, Jingbo Wang, Chang Su, Yueting Li, Dianrong Ma, Minghui Zhao, Wenfu Chen	5
12	Adherence to and determinants of guideline‐recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice 2021 ·Cancer ·Kelsey S. Lau‐Min, Yimei Li, Jennifer R. Eads, Xiaoliang Wang, Neal J. Meropol, Ronac Mamtani, Kelly Getz	1
13	Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk 2018 ·Cancer Research ·Xiaoliang Wang, Andrew T. Chan, Martha L. Slattery, Jenny Chang‐Claude, John D. Potter, Steven Gallinger, Bette J. Caan, Johanna W. Lampe, Polly A. Newcomb, Niha Zubair, Li Hsu, Robert E. Schoen, Michael Hoffmeister, Hermann Brenner, Loı̈c Le Marchand, Ulrike Peters, Emily White	26
14	Loperamide inhibits sodium channels to alleviate inflammatory hyperalgesia 2017 ·Neuropharmacology ·Ying Wu, Beiyan Zou, Lingli Liang, Min Li, Yuan‐Xiang Tao, Haibo Yu, Xiaoliang Wang	16
15	Investigation on natural resources and species conservation of Ophiocordyceps sinensis, the famous medicinal fungus endemic to the Tibetan Plateau 2017 ·Protein & Cell ·Wenjing Wang, Ke Wang, Xiaoliang Wang, Rui‐Heng Yang, (unknown), Yi‐Jian Yao	3
16	Effects of Stocking Rate on the Variability of Peak Standing Crop in a Desert Steppe of Eurasia Grassland 2013 ·Environmental Management ·Zhongwu Wang, (unknown), Guodong Han, Mengli Zhao, (unknown), Xinjie Zhang, Xiaoliang Wang, (unknown), Walter D. Willms, (unknown), (unknown), Yongzhi Liu	40
17	Digital Transcript Profile Analysis with aRNA-LongSAGE Validates FERMT1 As a Potential Novel Prognostic Marker for Colon Cancer 2011 ·Clinical Cancer Research ·Junwei Fan, Dongwang Yan, Mujian Teng, Huamei Tang, Chongzhi Zhou, Xiaoliang Wang, Dawei Li, Guoqiang Qiu, Zhihai Peng	22
18	IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis 2009 ·Annals of Surgical Oncology ·Dawei Li, Dongwang Yan, Huamei Tang, Chongzhi Zhou, Junwei Fan, Shuxia Li, Xiaoliang Wang, Jun Xia, Fei Huang, Guoqiang Qiu, Zhihai Peng	94
19	Distinguishing Between Poem and Picture——Enlightenment of Lessing’s "Laocoon" 2007 ·Xiaoliang Wang	0
20	Diverse Effects of <italic>L</italic>-arginine on Cardiac Function of Rats Subjected to Myocardial Ischemia and Reperfusion <italic>in vivo</italic> 2007 ·Acta Biochimica et Biophysica Sinica ·Xiaoliang Wang, Feng Liang, Xiangying Jiao, Lei Liu, Xiaojie Bai, Meixia Li, (unknown), Huirong Liu	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact